Loading provider…
Loading provider…
Neurology Physician in Naples, FL
NPI: 1275583916Primary Practice Location
Collier Neurologic Specialists LLC
730 Goodlette N Rd, Naples, FL
Primary Employer
Collier Neurologic Specialists LLC
collierneurologic.com
HQ Phone
Get MD William's Phone Numberphone_androidMobile
Get MD William's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1998 - 2026
TX State Medical License
1995 - 2000

American Board of Psychiatry and Neurology
Neurology
University of Miami, Miller School of Medicine
med.miami.edu
Medical School
Until 1994
University of Texas Health Science Center at Houston
Fellowship • Clinical Neurophysiology
1998 - 1999
Residency • Neurology
1995 - 1998
Internship • Internal Medicine
1994 - 1995
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 652 | 1,331 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 224 | 224 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 205 | 244 |
| 4 | 95886Needle measurement and recording of electrical activity of muscles of arm or leg complete study | 45 | 87 |
| 5 | 95910Nerve transmission studies, 7-8 studies | 20 | 20 |
'Benign monomelic amyotrophy of the lower extremity: report of two cases and
Authors: Mazen M. Dimachkie, William Justiz, Francine J. Vriesendorp
Publication Date: 2000-06
Lead Sponsor: Alzheon Inc.
Collaborators: National Institute on Aging (NIA)
Intervention / Treatment: DRUG: Experimental: ALZ-801, DRUG: Placebo Comparator: Placebo
Lead Sponsor: Suven Life Sciences Limited
Intervention / Treatment: DRUG: Placebo, DRUG: Memantine, DRUG: Donepezil, DRUG: SUVN-502
Lead Sponsor: ACADIA Pharmaceuticals Inc.
Intervention / Treatment: OTHER: Placebo, DRUG: Pimavanserin 20 mg, DRUG: Pimavanserin 34 mg